View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
November 28, 2011

Drug maker Merck initiates legal action against Facebook

Merck KGaA is miffed with the "apparent takeover" of its account by American Merck & Co

By CBR Staff Writer

German drug manufacturer Merck KGaA has initiated legal proceedings against Facebook for the "apparent takeover" of the account by the American drug maker Merck & Co.

Merck KGaA spokesperson told BBC News that it took legal action versus Facebook to ask for information as to why a website it thought it owned isn’t its anymore.

Merck KGaA said it requires "pre-action disclosure from Facebook to determine the nature of the misconduct, to frame the pleadings, and to identify the proper defendants."

Merck KGaA, in the filing, said because Facebook is an important marketing device, the page is of great value, and its misappropriation is causing harm to the company.

According to Merck KGaA website, Merck & Co. was formed in 1891, but became an independent American entity after World War I.

Content from our partners
Unlocking growth through hybrid cloud: 5 key takeaways
How businesses can safeguard themselves on the cyber frontline
How hackers’ tactics are evolving in an increasingly complex landscape

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.